nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—Angina pectoris—Liothyronine—hypothyroidism	0.0346	0.039	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0313	0.0351	CcSEcCtD
Fenoldopam—Myocardial infarction—Liothyronine—hypothyroidism	0.0311	0.0349	CcSEcCtD
Fenoldopam—Oliguria—Liotrix—hypothyroidism	0.0222	0.025	CcSEcCtD
Fenoldopam—Creatinine increased—Liotrix—hypothyroidism	0.0215	0.0242	CcSEcCtD
Fenoldopam—Cardiac failure—Dextrothyroxine—hypothyroidism	0.0207	0.0233	CcSEcCtD
Fenoldopam—Cardiac failure—Levothyroxine—hypothyroidism	0.0207	0.0233	CcSEcCtD
Fenoldopam—Tachycardia—Liothyronine—hypothyroidism	0.0197	0.0222	CcSEcCtD
Fenoldopam—Blood urea increased—Liotrix—hypothyroidism	0.0193	0.0217	CcSEcCtD
Fenoldopam—Hypotension—Liothyronine—hypothyroidism	0.0189	0.0212	CcSEcCtD
Fenoldopam—Angina pectoris—Levothyroxine—hypothyroidism	0.017	0.0191	CcSEcCtD
Fenoldopam—Angina pectoris—Dextrothyroxine—hypothyroidism	0.017	0.0191	CcSEcCtD
Fenoldopam—Body temperature increased—Liothyronine—hypothyroidism	0.016	0.018	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.0154	0.0173	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.0154	0.0173	CcSEcCtD
Fenoldopam—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.0153	0.0172	CcSEcCtD
Fenoldopam—Myocardial infarction—Levothyroxine—hypothyroidism	0.0153	0.0172	CcSEcCtD
Fenoldopam—Cardiac failure—Liotrix—hypothyroidism	0.0152	0.0171	CcSEcCtD
Fenoldopam—Sweating—Levothyroxine—hypothyroidism	0.0149	0.0168	CcSEcCtD
Fenoldopam—Sweating—Dextrothyroxine—hypothyroidism	0.0149	0.0168	CcSEcCtD
Fenoldopam—Blood creatinine increased—Liotrix—hypothyroidism	0.0139	0.0157	CcSEcCtD
Fenoldopam—Hypokalaemia—Liotrix—hypothyroidism	0.0135	0.0152	CcSEcCtD
Fenoldopam—DRD1—nerve—hypothyroidism	0.0133	0.166	CbGeAlD
Fenoldopam—Flushing—Dextrothyroxine—hypothyroidism	0.013	0.0146	CcSEcCtD
Fenoldopam—Flushing—Levothyroxine—hypothyroidism	0.013	0.0146	CcSEcCtD
Fenoldopam—Angina pectoris—Liotrix—hypothyroidism	0.0125	0.0141	CcSEcCtD
Fenoldopam—Tension—Levothyroxine—hypothyroidism	0.0119	0.0134	CcSEcCtD
Fenoldopam—Tension—Dextrothyroxine—hypothyroidism	0.0119	0.0134	CcSEcCtD
Fenoldopam—Nervousness—Dextrothyroxine—hypothyroidism	0.0118	0.0133	CcSEcCtD
Fenoldopam—Nervousness—Levothyroxine—hypothyroidism	0.0118	0.0133	CcSEcCtD
Fenoldopam—Acute coronary syndrome—Liotrix—hypothyroidism	0.0113	0.0127	CcSEcCtD
Fenoldopam—Myocardial infarction—Liotrix—hypothyroidism	0.0112	0.0126	CcSEcCtD
Fenoldopam—Sweating—Liotrix—hypothyroidism	0.011	0.0123	CcSEcCtD
Fenoldopam—Palpitations—Dextrothyroxine—hypothyroidism	0.0108	0.0121	CcSEcCtD
Fenoldopam—Palpitations—Levothyroxine—hypothyroidism	0.0108	0.0121	CcSEcCtD
Fenoldopam—Anxiety—Dextrothyroxine—hypothyroidism	0.0103	0.0116	CcSEcCtD
Fenoldopam—Anxiety—Levothyroxine—hypothyroidism	0.0103	0.0116	CcSEcCtD
Fenoldopam—Tachycardia—Dextrothyroxine—hypothyroidism	0.00969	0.0109	CcSEcCtD
Fenoldopam—Tachycardia—Levothyroxine—hypothyroidism	0.00969	0.0109	CcSEcCtD
Fenoldopam—Hyperhidrosis—Levothyroxine—hypothyroidism	0.0096	0.0108	CcSEcCtD
Fenoldopam—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.0096	0.0108	CcSEcCtD
Fenoldopam—Flushing—Liotrix—hypothyroidism	0.00954	0.0107	CcSEcCtD
Fenoldopam—Insomnia—Levothyroxine—hypothyroidism	0.00898	0.0101	CcSEcCtD
Fenoldopam—Insomnia—Dextrothyroxine—hypothyroidism	0.00898	0.0101	CcSEcCtD
Fenoldopam—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00885	0.00996	CcSEcCtD
Fenoldopam—Dyspnoea—Levothyroxine—hypothyroidism	0.00885	0.00996	CcSEcCtD
Fenoldopam—Tension—Liotrix—hypothyroidism	0.00878	0.00988	CcSEcCtD
Fenoldopam—Nervousness—Liotrix—hypothyroidism	0.00869	0.00978	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00812	0.00913	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00812	0.00913	CcSEcCtD
Fenoldopam—Palpitations—Liotrix—hypothyroidism	0.00791	0.00889	CcSEcCtD
Fenoldopam—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00785	0.00883	CcSEcCtD
Fenoldopam—Abdominal pain—Levothyroxine—hypothyroidism	0.00785	0.00883	CcSEcCtD
Fenoldopam—Body temperature increased—Levothyroxine—hypothyroidism	0.00785	0.00883	CcSEcCtD
Fenoldopam—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00785	0.00883	CcSEcCtD
Fenoldopam—DRD2—nerve—hypothyroidism	0.00784	0.0983	CbGeAlD
Fenoldopam—Chest pain—Liotrix—hypothyroidism	0.00762	0.00857	CcSEcCtD
Fenoldopam—Anxiety—Liotrix—hypothyroidism	0.00759	0.00854	CcSEcCtD
Fenoldopam—Tachycardia—Liotrix—hypothyroidism	0.00713	0.00802	CcSEcCtD
Fenoldopam—Hyperhidrosis—Liotrix—hypothyroidism	0.00706	0.00794	CcSEcCtD
Fenoldopam—Hypotension—Liotrix—hypothyroidism	0.00683	0.00768	CcSEcCtD
Fenoldopam—Diarrhoea—Dextrothyroxine—hypothyroidism	0.0068	0.00764	CcSEcCtD
Fenoldopam—Diarrhoea—Levothyroxine—hypothyroidism	0.0068	0.00764	CcSEcCtD
Fenoldopam—Insomnia—Liotrix—hypothyroidism	0.00661	0.00743	CcSEcCtD
Fenoldopam—Dyspnoea—Liotrix—hypothyroidism	0.00651	0.00732	CcSEcCtD
Fenoldopam—Vomiting—Levothyroxine—hypothyroidism	0.00632	0.0071	CcSEcCtD
Fenoldopam—Vomiting—Dextrothyroxine—hypothyroidism	0.00632	0.0071	CcSEcCtD
Fenoldopam—Constipation—Liotrix—hypothyroidism	0.00625	0.00702	CcSEcCtD
Fenoldopam—Headache—Dextrothyroxine—hypothyroidism	0.00622	0.007	CcSEcCtD
Fenoldopam—Headache—Levothyroxine—hypothyroidism	0.00622	0.007	CcSEcCtD
Fenoldopam—Gastrointestinal pain—Liotrix—hypothyroidism	0.00597	0.00672	CcSEcCtD
Fenoldopam—Nausea—Dextrothyroxine—hypothyroidism	0.0059	0.00663	CcSEcCtD
Fenoldopam—Nausea—Levothyroxine—hypothyroidism	0.0059	0.00663	CcSEcCtD
Fenoldopam—Abdominal pain—Liotrix—hypothyroidism	0.00578	0.00649	CcSEcCtD
Fenoldopam—Body temperature increased—Liotrix—hypothyroidism	0.00578	0.00649	CcSEcCtD
Fenoldopam—Diarrhoea—Liotrix—hypothyroidism	0.005	0.00562	CcSEcCtD
Fenoldopam—Dizziness—Liotrix—hypothyroidism	0.00483	0.00543	CcSEcCtD
Fenoldopam—Vomiting—Liotrix—hypothyroidism	0.00465	0.00522	CcSEcCtD
Fenoldopam—Headache—Liotrix—hypothyroidism	0.00458	0.00515	CcSEcCtD
Fenoldopam—DRD5—female gonad—hypothyroidism	0.00449	0.0563	CbGeAlD
Fenoldopam—Nausea—Liotrix—hypothyroidism	0.00434	0.00488	CcSEcCtD
Fenoldopam—ADRA1A—heart—hypothyroidism	0.00297	0.0372	CbGeAlD
Fenoldopam—ADRA2C—adrenal cortex—hypothyroidism	0.00293	0.0367	CbGeAlD
Fenoldopam—ADRA2C—heart—hypothyroidism	0.00283	0.0355	CbGeAlD
Fenoldopam—ADRA1A—cardiovascular system—hypothyroidism	0.0028	0.0351	CbGeAlD
Fenoldopam—DRD2—pituitary gland—hypothyroidism	0.00243	0.0305	CbGeAlD
Fenoldopam—ADRA2C—pituitary gland—hypothyroidism	0.00236	0.0296	CbGeAlD
Fenoldopam—ADRA2A—heart—hypothyroidism	0.00226	0.0283	CbGeAlD
Fenoldopam—ADRA1A—adrenal gland—hypothyroidism	0.00222	0.0278	CbGeAlD
Fenoldopam—ADRA1A—blood—hypothyroidism	0.00222	0.0278	CbGeAlD
Fenoldopam—ADRA2C—adrenal gland—hypothyroidism	0.00211	0.0265	CbGeAlD
Fenoldopam—ADRA2C—blood—hypothyroidism	0.00211	0.0265	CbGeAlD
Fenoldopam—ADRA2C—female gonad—hypothyroidism	0.00197	0.0247	CbGeAlD
Fenoldopam—ADRA2A—gonad—hypothyroidism	0.00193	0.0242	CbGeAlD
Fenoldopam—ADRA2A—pituitary gland—hypothyroidism	0.00189	0.0236	CbGeAlD
Fenoldopam—DRD2—testis—hypothyroidism	0.0018	0.0225	CbGeAlD
Fenoldopam—ADRA2C—testis—hypothyroidism	0.00175	0.0219	CbGeAlD
Fenoldopam—ADRA1A—liver—hypothyroidism	0.00173	0.0217	CbGeAlD
Fenoldopam—ADRA1A—cerebellum—hypothyroidism	0.00169	0.0212	CbGeAlD
Fenoldopam—ADRA2A—adrenal gland—hypothyroidism	0.00169	0.0211	CbGeAlD
Fenoldopam—ADRA2A—blood—hypothyroidism	0.00168	0.0211	CbGeAlD
Fenoldopam—DRD2—cerebellum—hypothyroidism	0.00166	0.0208	CbGeAlD
Fenoldopam—ADRA2C—liver—hypothyroidism	0.00165	0.0207	CbGeAlD
Fenoldopam—ADRA2A—thyroid gland—hypothyroidism	0.00163	0.0204	CbGeAlD
Fenoldopam—ADRA2C—cerebellum—hypothyroidism	0.00161	0.0202	CbGeAlD
Fenoldopam—ADRA2A—female gonad—hypothyroidism	0.00157	0.0197	CbGeAlD
Fenoldopam—ADRA2A—testis—hypothyroidism	0.00139	0.0175	CbGeAlD
Fenoldopam—ADRA2A—cerebellum—hypothyroidism	0.00129	0.0161	CbGeAlD
Fenoldopam—ADRA2A—GPCR ligand binding—TSHR—hypothyroidism	0.000101	0.00329	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—SH2B3—hypothyroidism	9.95e-05	0.00323	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—IYD—hypothyroidism	9.93e-05	0.00323	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—TPO—hypothyroidism	9.78e-05	0.00318	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	9.66e-05	0.00314	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—TRH—hypothyroidism	9.51e-05	0.00309	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	9.51e-05	0.00309	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—TRH—hypothyroidism	9.39e-05	0.00305	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CLTC—hypothyroidism	8.89e-05	0.00289	CbGpPWpGaD
Fenoldopam—DRD5—GPCR ligand binding—POMC—hypothyroidism	8.85e-05	0.00287	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—AVP—hypothyroidism	8.84e-05	0.00287	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	8.77e-05	0.00285	CbGpPWpGaD
Fenoldopam—ADRA2B—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	8.74e-05	0.00284	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—AVP—hypothyroidism	8.73e-05	0.00283	CbGpPWpGaD
Fenoldopam—ADRA2B—G alpha (i) signalling events—POMC—hypothyroidism	8.65e-05	0.00281	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—TRH—hypothyroidism	8.64e-05	0.00281	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—TRH—hypothyroidism	8.52e-05	0.00277	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—TSHB—hypothyroidism	8.48e-05	0.00275	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—TSHR—hypothyroidism	8.48e-05	0.00275	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—TRH—hypothyroidism	8.48e-05	0.00275	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	8.45e-05	0.00274	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ATP5O—hypothyroidism	8.45e-05	0.00274	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—TSHB—hypothyroidism	8.37e-05	0.00272	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—TSHR—hypothyroidism	8.37e-05	0.00272	CbGpPWpGaD
Fenoldopam—ADRA2C—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	8.16e-05	0.00265	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—SH2B3—hypothyroidism	8.08e-05	0.00263	CbGpPWpGaD
Fenoldopam—ADRA2C—G alpha (i) signalling events—POMC—hypothyroidism	8.08e-05	0.00262	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—TPO—hypothyroidism	7.94e-05	0.00258	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—TRH—hypothyroidism	7.92e-05	0.00257	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—AVP—hypothyroidism	7.88e-05	0.00256	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	7.85e-05	0.00255	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—VAV3—hypothyroidism	7.81e-05	0.00254	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—TRH—hypothyroidism	7.79e-05	0.00253	CbGpPWpGaD
Fenoldopam—DRD1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.72e-05	0.00251	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—TSHB—hypothyroidism	7.7e-05	0.0025	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—TSHR—hypothyroidism	7.7e-05	0.0025	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TRH—hypothyroidism	7.7e-05	0.0025	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TRH—hypothyroidism	7.68e-05	0.0025	CbGpPWpGaD
Fenoldopam—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	7.61e-05	0.00247	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—TSHB—hypothyroidism	7.6e-05	0.00247	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—TSHR—hypothyroidism	7.6e-05	0.00247	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—TSHB—hypothyroidism	7.55e-05	0.00245	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—TSHR—hypothyroidism	7.55e-05	0.00245	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—AVP—hypothyroidism	7.52e-05	0.00244	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—AVP—hypothyroidism	7.36e-05	0.00239	CbGpPWpGaD
Fenoldopam—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	7.33e-05	0.00238	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—VAV3—hypothyroidism	7.31e-05	0.00238	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—AVP—hypothyroidism	7.24e-05	0.00235	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TRH—hypothyroidism	7.19e-05	0.00234	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—TRH—hypothyroidism	7.18e-05	0.00233	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—VAV3—hypothyroidism	7.09e-05	0.0023	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TRH—hypothyroidism	7.08e-05	0.0023	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—TSHB—hypothyroidism	7.06e-05	0.00229	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—TSHR—hypothyroidism	7.06e-05	0.00229	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—TSHB—hypothyroidism	6.94e-05	0.00226	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—TSHR—hypothyroidism	6.94e-05	0.00226	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	6.92e-05	0.00225	CbGpPWpGaD
Fenoldopam—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	6.87e-05	0.00223	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TSHB—hypothyroidism	6.86e-05	0.00223	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—TSHR—hypothyroidism	6.86e-05	0.00223	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TSHB—hypothyroidism	6.85e-05	0.00222	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TSHR—hypothyroidism	6.85e-05	0.00222	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—AVP—hypothyroidism	6.83e-05	0.00222	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—VAV3—hypothyroidism	6.83e-05	0.00222	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—AVP—hypothyroidism	6.68e-05	0.00217	CbGpPWpGaD
Fenoldopam—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	6.63e-05	0.00215	CbGpPWpGaD
Fenoldopam—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	6.56e-05	0.00213	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TRH—hypothyroidism	6.52e-05	0.00212	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	6.43e-05	0.00209	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	6.43e-05	0.00209	CbGpPWpGaD
Fenoldopam—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	6.42e-05	0.00209	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TSHB—hypothyroidism	6.41e-05	0.00208	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—TSHR—hypothyroidism	6.41e-05	0.00208	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	6.4e-05	0.00208	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	6.4e-05	0.00208	CbGpPWpGaD
Fenoldopam—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	6.32e-05	0.00205	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	6.31e-05	0.00205	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	6.31e-05	0.00205	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	6.28e-05	0.00204	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	6.17e-05	0.002	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	6.17e-05	0.002	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—SH2B3—hypothyroidism	6.1e-05	0.00198	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	5.98e-05	0.00194	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CLTC—hypothyroidism	5.91e-05	0.00192	CbGpPWpGaD
Fenoldopam—DRD1—GPCR ligand binding—POMC—hypothyroidism	5.88e-05	0.00191	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	5.84e-05	0.0019	CbGpPWpGaD
Fenoldopam—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.83e-05	0.00189	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CLTC—hypothyroidism	5.83e-05	0.00189	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TSHB—hypothyroidism	5.81e-05	0.00189	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—TSHR—hypothyroidism	5.81e-05	0.00189	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—POMC—hypothyroidism	5.8e-05	0.00188	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	5.73e-05	0.00186	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	5.73e-05	0.00186	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.61e-05	0.00182	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	5.6e-05	0.00182	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	5.6e-05	0.00182	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—VAV3—hypothyroidism	5.55e-05	0.0018	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	5.26e-05	0.00171	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	5.24e-05	0.0017	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.22e-05	0.00169	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	5.2e-05	0.00169	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	5.2e-05	0.00169	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—VAV3—hypothyroidism	5.19e-05	0.00168	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—VAV3—hypothyroidism	5.12e-05	0.00166	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TRH—hypothyroidism	5.1e-05	0.00166	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TRH—hypothyroidism	5.04e-05	0.00164	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—POMC—hypothyroidism	5e-05	0.00162	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—AVP—hypothyroidism	5e-05	0.00162	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	4.93e-05	0.0016	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	4.91e-05	0.0016	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	4.89e-05	0.00159	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	4.84e-05	0.00157	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	4.81e-05	0.00156	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—VAV3—hypothyroidism	4.71e-05	0.00153	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	4.65e-05	0.00151	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	4.62e-05	0.0015	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TSHB—hypothyroidism	4.55e-05	0.00148	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TSHR—hypothyroidism	4.55e-05	0.00148	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TRH—hypothyroidism	4.55e-05	0.00148	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—POMC—hypothyroidism	4.54e-05	0.00147	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—AVP—hypothyroidism	4.54e-05	0.00147	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PRL—hypothyroidism	4.53e-05	0.00147	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—TSHB—hypothyroidism	4.53e-05	0.00147	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—IGF1—hypothyroidism	4.5e-05	0.00146	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	4.49e-05	0.00146	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	4.49e-05	0.00146	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	4.48e-05	0.00145	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CLTC—hypothyroidism	4.46e-05	0.00145	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	4.45e-05	0.00145	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—POMC—hypothyroidism	4.44e-05	0.00144	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	4.32e-05	0.0014	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	4.3e-05	0.0014	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	4.28e-05	0.00139	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	4.25e-05	0.00138	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TRH—hypothyroidism	4.25e-05	0.00138	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—IGF1—hypothyroidism	4.21e-05	0.00137	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	4.2e-05	0.00136	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—VAV3—hypothyroidism	4.19e-05	0.00136	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TRH—hypothyroidism	4.18e-05	0.00136	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	4.16e-05	0.00135	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	4.09e-05	0.00133	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SH2B3—hypothyroidism	4.05e-05	0.00132	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	4.05e-05	0.00132	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	4.05e-05	0.00132	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	4.04e-05	0.00131	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—AVP—hypothyroidism	4.04e-05	0.00131	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	4.03e-05	0.00131	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	4e-05	0.0013	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	3.99e-05	0.0013	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	3.97e-05	0.00129	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	3.92e-05	0.00127	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	3.92e-05	0.00127	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	3.86e-05	0.00125	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TRH—hypothyroidism	3.85e-05	0.00125	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	3.79e-05	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	3.79e-05	0.00123	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	3.78e-05	0.00123	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	3.77e-05	0.00123	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—AVP—hypothyroidism	3.77e-05	0.00123	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	3.73e-05	0.00121	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	3.73e-05	0.00121	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	3.72e-05	0.00121	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TRH—hypothyroidism	3.71e-05	0.00121	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—TSHB—hypothyroidism	3.68e-05	0.00119	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	3.64e-05	0.00118	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	3.61e-05	0.00117	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—VAV3—hypothyroidism	3.56e-05	0.00116	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	3.51e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TRH—hypothyroidism	3.45e-05	0.00112	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TSHB—hypothyroidism	3.43e-05	0.00112	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TSHR—hypothyroidism	3.43e-05	0.00112	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	3.43e-05	0.00111	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—AVP—hypothyroidism	3.43e-05	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—IGF1—hypothyroidism	3.42e-05	0.00111	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—SLC5A5—hypothyroidism	3.39e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	3.38e-05	0.0011	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	3.37e-05	0.0011	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—POMC—hypothyroidism	3.32e-05	0.00108	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	3.32e-05	0.00108	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	3.31e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	3.31e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	3.3e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	3.28e-05	0.00106	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	3.28e-05	0.00106	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	3.18e-05	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	3.07e-05	0.000999	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	3.07e-05	0.000999	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	3.07e-05	0.000996	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SH2B3—hypothyroidism	3.06e-05	0.000994	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—POMC—hypothyroidism	3.02e-05	0.00098	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PRL—hypothyroidism	3.01e-05	0.000977	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	2.98e-05	0.000967	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PRL—hypothyroidism	2.97e-05	0.000964	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	2.96e-05	0.000961	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	2.95e-05	0.000958	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—VAV3—hypothyroidism	2.78e-05	0.000904	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	2.76e-05	0.000898	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—SLC5A5—hypothyroidism	2.75e-05	0.000894	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	2.75e-05	0.000892	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	2.74e-05	0.00089	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	2.72e-05	0.000883	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	2.69e-05	0.000873	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—POMC—hypothyroidism	2.68e-05	0.000871	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—AVP—hypothyroidism	2.68e-05	0.000871	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PRL—hypothyroidism	2.68e-05	0.00087	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—AVP—hypothyroidism	2.65e-05	0.000859	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IGF1—hypothyroidism	2.58e-05	0.000838	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	2.51e-05	0.000815	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—POMC—hypothyroidism	2.51e-05	0.000814	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PRL—hypothyroidism	2.5e-05	0.000813	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	2.48e-05	0.000805	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	2.47e-05	0.000802	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PRL—hypothyroidism	2.46e-05	0.0008	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	2.42e-05	0.000785	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—AVP—hypothyroidism	2.39e-05	0.000776	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	2.32e-05	0.000752	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	2.28e-05	0.00074	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—POMC—hypothyroidism	2.28e-05	0.00074	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRL—hypothyroidism	2.27e-05	0.000738	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	2.24e-05	0.000729	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—AVP—hypothyroidism	2.23e-05	0.000725	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—AVP—hypothyroidism	2.2e-05	0.000713	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	2.19e-05	0.000713	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRL—hypothyroidism	2.19e-05	0.000711	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—VAV3—hypothyroidism	2.1e-05	0.000682	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	2.04e-05	0.000662	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRL—hypothyroidism	2.03e-05	0.00066	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	2.02e-05	0.000657	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—AVP—hypothyroidism	2.02e-05	0.000657	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—AVP—hypothyroidism	1.95e-05	0.000633	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	1.88e-05	0.000611	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—AVP—hypothyroidism	1.81e-05	0.000589	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—POMC—hypothyroidism	1.78e-05	0.000579	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—POMC—hypothyroidism	1.77e-05	0.000576	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—POMC—hypothyroidism	1.76e-05	0.000571	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IGF1—hypothyroidism	1.71e-05	0.000557	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	1.69e-05	0.000549	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—POMC—hypothyroidism	1.59e-05	0.000516	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	1.53e-05	0.000496	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—hypothyroidism	1.48e-05	0.000482	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—hypothyroidism	1.46e-05	0.000474	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—hypothyroidism	1.44e-05	0.000468	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	1.43e-05	0.000463	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	1.4e-05	0.000456	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—hypothyroidism	1.35e-05	0.000437	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—hypothyroidism	1.3e-05	0.000421	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.29e-05	0.00042	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.25e-05	0.000405	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.2e-05	0.000391	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	1.16e-05	0.000376	CbGpPWpGaD
